Psyence Biomedical Ltd. (PBM) Shares Outstanding (2023 - 2026)
Psyence Biomedical (PBM) posted quarterly Shares Outstanding (Entity) of $552282.0 for Q1 2026, up 1688.07% year-over-year from $30887.0 in Q1 2025, and up 132.99% quarter-over-quarter from $237044.0 in Q3 2025.
Psyence Biomedical Ltd. (PBM) Shares Outstanding (2023 - 2026) Analysis & Trends
Psyence Biomedical's Shares Outstanding (Entity) history runs 4 years deep, the most recent figure standing at $552282.0 for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 1688.07% year-over-year to $552282.0; the TTM figure through Mar 2026 stood at $552282.0 (up 1688.07% YoY), while the FY2026 annual figure was $552282.0, up 1688.07% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $552282.0, up from $237044.0 in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $552282.0 in Q1 2026, with the low at $1338.0 in Q1 2023.
- The 4-year median for Shares Outstanding (Entity) is $5555.0 (2024), against an average of $118657.0.
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) surged 30.34% in 2024, then surged 4167.22% in 2025.
- Psyence Biomedical's Shares Outstanding (Entity) stood at $1749.0 in 2023, then jumped by 217.61% to $5555.0 in 2024, then soared by 4167.22% to $237044.0 in 2025, then soared by 132.99% to $552282.0 in 2026.
- Business Quant data shows PBM's Shares Outstanding (Entity) at $552282.0 in Q1 2026, $237044.0 in Q3 2025, and $30887.0 in Q1 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 552,282.00 |
| Sep 30, 2025 | 237,044.00 |
| Mar 31, 2025 | 30,887.00 |
| Sep 30, 2024 | 5,555.00 |
| Mar 31, 2024 | 1,744.00 |
| Sep 30, 2023 | 1,749.00 |
| Mar 31, 2023 | 1,338.00 |